Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.05.05.539530

Genomic analysis reveals the presence of emerging pathogenic Klebsiella lineages aboard the International Space Station.

Abstract

Klebsiella species, including Klebsiella pneumoniae, Klebsiella aerogenes, and Klebsiella quasipneumoniae, are opportunistic pathogens that are known to cause infections in humans. Hypervirulent Klebsiella pneumoniae (hvKP) is a subgroup of K. pneumoniae that has gained attention due to its global dissemination and its ability to cause invasive infections in community settings amongst immunocompetent individuals as well as its increasing levels of antibiotic resistance. Our study reports the first complete genotypic analysis including mobile genetic elements (MGEs) of Klebsiella isolates from the International Space Station (ISS). The genomes of K. pneumoniae, K. aerogenes, and K. quasipneumoniae provided valuable insights into their antimicrobial resistance, virulence, thermotolerance, disinfectant resistance, and MGEs. All isolates belonged to emerging lineages with pathogenic potential, with K. quasipneumoniae ST138 presenting spatial and temporal persistence aboard the ISS, possibly due to its genotypic profile encoding for numerous resistance genes to disinfectants and heavy metals. We also report on the isolation of a yersiniabactin encoding K. pneumoniae, belonging to the emerging high-risk ST101 clone, aboard the ISS. Potential dissemination of hvKp strains on ISS could pose a putative risk to the immunocompromised crew. The presence of MGEs containing virulent loci could facilitate horizontal gene transfer to other benign microorganisms on the ISS, potentially increasing their virulence. In addition, genetic divergence from their respective lineages for some Klebsiella genomes was predicted and hypothesized to be due to the unique spaceflight environmental pressures. These findings highlight the importance of monitoring problematic microbial communities in space to understand their surviving abilities and potential impact on human health. ImportanceThe International Space Station (ISS) is a unique hermetically sealed environment that poses environmental pressures not encountered on Earth, including microgravity and radiation While the adaptability of bacteria during spaceflight is not fully understood, recent research has suggested that it may be species and even clone specific. Given the spaceflight-induced suppression of the human immune system, it is essential to understand the genomics of potential human pathogens in spaceflight. Such understanding could provide valuable insights into species and lineages of medical astromicrobiological importance. Here, we used hybrid assembly approaches and comparative genomics to provide the first comprehensive genomic characterisation of 10 Klebsiella isolates retrieved from the ISS. Our findings revealed that K. quasipneumoniae ST138 exhibits spatial and temporal persistence aboard the ISS, with evidence of genomic divergence from the ST138 lineage on Earth. Additionally, we characterized plasmids from Klebsiella species of ISS origin, which encoded disinfectant and thermoresistance genes suggesting that these might aid adaptability. Furthermore, we identified an MGE containing a hypervirulence-associated locus belonging to a Klebsiella pneumoniae isolate of the "high risk" ST101 clone. Our work provides valuable insights into the adaptability and persistence of Klebsiella species during spaceflight, highlighting the importance of understanding the behaviour of potential pathogenic bacteria in space.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Miliotis, G., Singh, N. K., McDonagh, F., O'Connor, L., Tuohy, A., Morris, D., Venkateswaran, K.. 2023-05-05. Genomic analysis reveals the presence of emerging pathogenic Klebsiella lineages aboard the International Space Station.. https://doi.org/10.1101/2023.05.05.539530

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Reverse Transcription Loop-Mediated Isothermal Amplification Combined with Lateral Flow Assay (RT-LAMP-LFA) for Rapid Detection of the 2026 Bundibugyo Virus (BDBV) Outbreak Strain

Making accurate diagnosis is a critical first step in patient management and control for emerging and re-emerging disease outbreaks. Bundibugyo virus (BDBV) is a filovirus that causes Ebola disease, and the 2026 outbreak highlights the need for rapid diagnostic approaches that can be deployed in settings with limited laboratory infrastructure. Here, we developed a reverse transcription loop-mediated isothermal amplification-lateral flow assay (RT-LAMP-LFA) for rapid detection of the 2026 BDBV outbreak strain. LAMP primers were designed based on the genome sequence of the 2026 outbreak strain, and the conservation of the primer binding sites among all available 2026 outbreak genomes was confirmed in silico. LAMP primers were evaluated for analytical specificity and sensitivity using in vitro-transcribed RNA (ivtRNA) from BDBV and other filoviruses, as well as RNA derived from arboviruses and mammalian cells. Amplification products were detected using a Chromatography-Printed Array Strip (C-PAS) lateral flow platform. The newly designed primers specifically detected the presence of BDBV RNA without nonspecific amplification of the other viral or cellular RNA samples tested. Consistent amplification was observed down to 103 copies per reaction. In addition, BDBV viral RNA was successfully amplified, and the amplification products were detected using C-PAS, with the total workflow being completed within 25 min. These findings demonstrate the analytical specificity and sensitivity of the developed RT-LAMP-LFA assay and its compatibility with rapid visual lateral flow detection, supporting its potential application as a point-of-care approach for BDBV detection.

microbiology↗

Divergent methane production and microbial community responses to carbon enrichment in freshwater wetland sediments

Methane (CH4) accumulation in wetland sediments reflects interactions among organic matter, sediment chemistry, and microbial communities. We combined depth-resolved field characterization across four wetland habitats in northern Israel with complementary incubations to examine methane accumulation and responses to labile-carbon enrichment. Sediment cores were characterized using Rock-Eval analysis, porewater chemistry, oxygen profiling at three sites, and mcrA amplicon sequencing. High CH4 concentrations occurred under contrasting conditions: Ein Nimfit (EN) contained approximately 12% total organic carbon and reached 2.1 mM CH4, whereas Ein Afek site EA2 contained approximately 5% carbon and accumulated 0.7-1.7 mM CH4. Both showed sulfate depletion, but EN exhibited pronounced sulfide accumulation, whereas EA2 showed greater dissolved iron and nutrient enrichment. Their classified methanogenic assemblages also differed. EA1 remained methane poor despite increasing carbon content with depth, while EA3 combined low carbon content and CH4 accumulation with detectable methanogens and lower methanogenic diversity. In a 36-day bottle experiments using sediments from two of the four wetland habitats, sucrose-amended EA3 exhibited a transient maximum of 18.8 mmol collected CH4 kg-1 wet sediment during Days 22-29, whereas EN reached its highest collected amount during Days 29-36. Methane proportions increased before the large output increase in EA3 but remained comparatively stable and high in EN. Soluble chemical oxygen demand trajectories and microbial community changes also differed. These findings identify distinct biogeochemical settings supporting methane accumulation and demonstrate methanogenic potential in low-CH4 sediment, emphasizing the complementary information provided by field profiles, microbial characterization, and exploratory enrichment experiments.

microbiology↗

The absence of microbiome in germ-free mice exacerbates the pathogenicity of mouse-adapted SARS-CoV-2 MA10

Germ-free mice, which are devoid of microbiota, provide a powerful system to define the contribution of the microbiome to host responses during infection. Severe COVID-19 outcomes are associated with multiple comorbidities that are themselves characterized by microbiome dysbiosis; however, the causal role of the microbiota in SARS-CoV-2 pathogenesis remains poorly understood. Here, we use germ-free mouse models to evaluate the impact of the microbiome on disease severity following infection with mouse-adapted SARS-CoV-2 MA10. Comparison with conventionally housed mice revealed that the absence of the microbiome markedly exacerbates SARS-CoV-2-induced disease in both C57BL/6 and Swiss Webster backgrounds. Germ-free mice exhibited greater weight loss, impaired lung function, worsened pulmonary pathology, and pronounced alterations in circulating cytokine and chemokine profiles compared with conventional controls. These findings show that resident microbiota limit SARS-CoV-2 pathogenicity and establish germ-free COVID-19 models as a powerful platform to identify protective microbial taxa and microbiota-based interventions to reduce severe disease.

microbiology↗